Magnolia Medical Technologies products

Steripath Gen2 is the simple, all-in-one solution clinically proven to reduce false positive blood culture results. Reduce your blood culture contamination rate to improve patient safety and key quality outcomes, while significantly reducing unnecessary antibiotic usage, length of stay and hospital costs.*

With Steripath Micro, you can consistently divert and sequester the skin contaminants known to cause false-positive blood culture results. The latest, low-volume Initial Specimen Diversion Device provides you with a reliable contamination-reducing technology for better patient outcomes and decreased cost burdens from a sepsis misdiagnosis.